Physician-led versus questionnaire-based psychosocial screening in adults with high-grade glioma: a cluster-randomized controlled trial (GLIOPT) - Summary - MDSpire

Physician-led versus questionnaire-based psychosocial screening in adults with high-grade glioma: a cluster-randomized controlled trial (GLIOPT)

  • By

  • Mirjam Renovanz

  • Melina Hippler

  • Robert Kuchen

  • Lorenz Doerner

  • David Rieger

  • Joachim P. Steinbach

  • Michael W. Ronellenfitsch

  • Martin Voss

  • Almuth F. Kessler

  • Vera Nickl

  • Martin Misch

  • Julia Sophie Onken

  • Marion Rapp

  • Minou Nadji-Ohl

  • Marcus Mehlitz

  • Jürgen Meixensberger

  • Michael Karl Fehrenbach

  • Naureen Keric

  • Florian Ringel

  • Jan Coburger

  • Carolin Weiß Lucas

  • Jens Wehinger

  • Friederike Schmidt-Graf

  • Jens Gempt

  • Marcos Tatagiba

  • Ghazaleh Tabatabai

  • Melanie Schranz

  • Susanne Singer

  • September 10, 2025

  • 0 min

Share

Objective:

To determine whether psychosocial assessment in patients with high-grade gliomas (HGG) could be improved by face-to-face evaluations during doctor-patient consultations, and to compare the effectiveness of these evaluations with standard questionnaire-based methods.

Key Findings:
  • The study aimed to improve identification and support of distressed patients with HGG, with evaluations conducted before and after consultations and follow-up assessments at 3 months.
  • Specific metrics on the percentage of patients identified as distressed and receiving care should be included.
Interpretation:

Integrating psychosocial screening into doctor-patient consultations may enhance the identification of patients needing support compared to standard questionnaire-based methods.

Limitations:
  • The study was non-blinded and conducted in a multicenter setting, which may introduce variability affecting the results.
  • The adaptation of screening tools may not fully address the diverse needs of neuro-oncological patients, potentially limiting the effectiveness of the intervention.
Conclusion:

The GLIOPT trial seeks to optimize psychosocial care for neuro-oncological patients by comparing two screening approaches, highlighting the potential benefits of integrating tailored assessments into clinical practice.

Original Source(s)

Related Content